RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MENCOBONI M
Collezione AOU Alessandria

Items : 5

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial. in Lancet (London, England) / Lancet. 2023 Dec 16;402(10419):2295-2306. doi: 10.1016/S0140-6736(23)01613-6. Epub 2023 Nov 3.

2023
AOU Alessandria

Chu Q; Perrone F; Greillier L; Tu W; Piccirillo MC; Grosso F; Lo Russo G; Florescu M; Mencoboni M; Morabito A; Cecere FL; Ceresoli GL; Dawe DE; Zucali PA; Pagano M; Goffin JR; Sanchez ML; Gridelli C; Zalcman G; Quantin X; Westeel V; Gargiulo P; Delfanti S; Tu D; Lee CW; Leighl N; Sederias J; Brown-Walker P; Luo Y; et alii...

Serum Extracellular Vesicle-Derived microRNAs as Potential Biomarkers for Pleural Mesothelioma in a European Prospective Study. in Cancers / Cancers (Basel). 2022 Dec 25;15(1):125. doi: 10.3390/cancers15010125.

2022
AOU Alessandria
AOU Città della Salute di Torino

Schulze MB; Trobajo-Sanmartín C; Heath AK; Riboli E; Huerta JM; Tumino R; Kaaks R; Johnson T; Agnoli C; Panico S; Smith-Byrne K; Rodriguez-Barranco M; Sacerdote C; Rena O; Filiberti RA; Mirabelli D; Grosso F; Dianzani I; Sculco M; Magnani C; Ferrante D; Mencoboni M; Catalano C; Allione A; Russo A; Pardini B; Birolo G; Casalone E; Saieva C; et alii...

Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma. in ESMO open / ESMO Open. 2022 Dec;7(6):100644. doi: 10.1016/j.esmoop.2022.100644. Epub 2022 Dec 1.

2022
AOU Alessandria

Canova S; Ceresoli GL; Grosso F; Zucali PA; Gelsomino F; Pasello G; Mencoboni M; Rulli E; Galli F; De Simone I; Carlucci L; De Angelis A; Belletti M; Bonomi M; D'Aveni A; Perrino M; Bono F; Cortinovis DL;

Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE. in Journal of bone oncology / J Bone Oncol. 2020 Dec 2;26:100341. doi: 10.1016/j.jbo.2020.100341. eCollection 2021 Feb.

2021
AOU Alessandria

Panebianco F; Carlini P; Sartori D; Lanzetta G; Mencoboni M; Acquati M; Fagnani D; Ceresoli GL; D'Angelillo RM; Chiuri VE; Guglielmini PF; Bordonaro R; Gasparro D; Cinieri S; Santini D; Beccaglia P; Procopio G;

Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2019 Dec;20(12):1702-1709. doi: 10.1016/S1470-2045(19)30532-7. Epub 2019 Oct 15.

2019
AOU Alessandria

Ceresoli GL; Aerts JG; Dziadziuszko R; Ramlau R; Cedres S; van Meerbeeck JP; Mencoboni M; Planchard D; Chella A; Crinò L; Krzakowski M; Rüssel J; Maconi A; Gianoncelli L; Grosso F;